PEGANONE Drug Patent Profile
Which patents cover Peganone, and what generic alternatives are available?
Peganone is a drug marketed by Recordati Rare and is included in one NDA.
The generic ingredient in PEGANONE is ethotoin. There is one drug master file entry for this compound. Additional details are available on the ethotoin profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PEGANONE?
- What are the global sales for PEGANONE?
- What is Average Wholesale Price for PEGANONE?
Summary for PEGANONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 53 |
| Patent Applications: | 3,007 |
| Drug Prices: | Drug price information for PEGANONE |
| What excipients (inactive ingredients) are in PEGANONE? | PEGANONE excipients list |
| DailyMed Link: | PEGANONE at DailyMed |
US Patents and Regulatory Information for PEGANONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recordati Rare | PEGANONE | ethotoin | TABLET;ORAL | 010841-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Recordati Rare | PEGANONE | ethotoin | TABLET;ORAL | 010841-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
